January 2018 Giving Report: $4 Million Match From Pineapple Fund

In January 2018, MAPS raised $1,148,633 in new donations and pledges from 720 supporters.

Starting on January 10, the Pineapple Fund has offered MAPS a $4 million matching grant for Phase 3 studies of MDMA-assisted psychotherapy for PTSD. The Pineapple Fund will match dollar-for-dollar all donations until March 10. Matching funds will be made in Bitcoin. If MAPS meets the match, we will have nearly funded our entire Phase 3 research for FDA approval of MDMA as a legal medicine. In January, MAPS has raised $744,041 toward the Pineapple Fund match.

In the same month, MAPS hosted four fundraising events across Colorado and California, which altogether raised $49,594 for Phase 3 research.

In August 2017, MAPS was granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA). This encouraging news demonstrates the FDA’s support and desire to expeditiously make MDMA into a legal medicine. Phase 3 studies will cost between $26-$35 million for both FDA and European Medicines Agency (EMA) approval. Additional expenses include research for other regulatory agencies around the world, therapist training, Expanded Access, and Phase 4 pediatric studies, which altogether will require at least $10 million more.

We extend a special thanks to those who so generously supported MAPS last month:

General Support:

  • Pineapple Fund ($33,455)
  • Spark Directed Fund ($10,000)
  • Matteo de Nora ($5,000)
  • Payam Panbechi ($2,346)
  • James D. Northrup ($1,000)
  • Anonymous ($1,000)
  • Peter Majerczak ($1,000)

MDMA/PTSD Phase 3 Studies:

  • Anonymous ($400,000)
  • Pineapple Fund ($292,369)
  • William H. Donner Foundation ($250,000)
  • George Goldsmith and Katya Malievskaia ($25,000)
  • Hub Spoke and Wheel ($10,850)
  • Devon Aoki and James Bailey ($10,000)
  • Paul and Kristina Eklund ($7,000)
  • Jeffrey Zucker ($5,000)
  • Anonymous ($2,000)
  • Mark C. Passerini, OM of Medicine ($1,200)
  • Sean McCabe ($1,000)
  • Allan M. Badiner ($1,000)
  • Anonymous ($1,000)
  • Anonymous ($1,000)
  • John H. Buchanan ($1,000)
  • Martin Chilcutt ($1,000)
  • Anonymous ($1,000)

MAPS relies on the generosity of individual donors to achieve our mission. Psychedelic science is again being conducted under federal guidelines, but no funding for psychedelic psychotherapy research is yet available from governments or major foundations.

Help us reach our goal to make MDMA a medicine by 2021 by establishing a monthly gift of $10 or more. maps.org/donate

Learn how to include MAPS in your will or estate plans.
Learn more about hosting a Global Psychedelic Dinner to fundraise for MAPS.